This inventor holds 1 USPTO granted patent. Top assignee: Novartis Corporation. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Marc-Olivier Bevierre
Introduction
Marc-Olivier Bevierre is a notable inventor based in Fontainebleau, France. He has made significant contributions to the field of biotechnology, particularly through his work on modified oligonucleotides. With a focus on advancing medical research, his innovations have the potential to impact various therapeutic areas.
Latest Patents
Marc-Olivier holds 1 patent for his work on modified oligonucleotides. This patent reflects his commitment to enhancing the efficacy of genetic materials, which can lead to breakthroughs in treatment methodologies.
Career Highlights
Currently, Marc-Olivier is employed at Novartis Corporation, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to innovative projects that aim to improve patient outcomes.
Collaborations
Throughout his career, Marc-Olivier has worked alongside esteemed colleagues such as Alain De Mesmaeker and Adrian Waldner. These collaborations have fostered a dynamic environment for innovation and have led to the development of cutting-edge solutions in biotechnology.
Conclusion
Marc-Olivier Bevierre's contributions to the field of biotechnology through his patent on modified oligonucleotides exemplify his dedication to advancing medical science. His work at Novartis Corporation and collaborations with other experts further highlight his impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile